Resoundant Acoustic Transducer for MRI - Safety Action
Summary
The French National Agency for Medicines and Health Products Safety (ANSM) has registered a safety action concerning the Resoundant acoustic transducer for MRI, identified under number R2606244. Healthcare facilities and medical imaging centers using this device have been notified.
What changed
The ANSM has recorded a safety action, designated R2606244, initiated by the company Resoundant regarding its acoustic transducer for magnetic resonance elastography. This action is specifically directed at healthcare facilities and medical imaging centers that utilize this device. The ANSM has been informed of the implementation of this safety measure, and affected users have received a direct communication from Resoundant, including a letter dated March 26, 2026.
Healthcare providers using the Resoundant acoustic transducer for MRI should review the safety communication and the attached letter from Resoundant for specific instructions and guidance. For any inquiries regarding this safety action, direct contact with Resoundant, the issuer of the action, is recommended. The ANSM's role here is to record and acknowledge the safety measure being implemented by the manufacturer.
What to do next
- Review the safety information and Resoundant's communication regarding the acoustic transducer.
- Contact Resoundant directly for any questions or specific guidance related to the safety action.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Information n° R2606244 destinée aux établissements de santé, centres d’imagerie médicale L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Resoundant.
Les utilisateurs concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2606244.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Resoundant (26/03/2026)
Related changes
Get daily alerts for ANSM Drug & Device Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from ANSM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.